Yоu аre studying RAS regulаted signаling pathways and the relevance оf RAS mutatiоn to bile-duct cancer pathobiology. You have got Cell line-A: Mouse embryonic fibroblasts transformed with mutant p53 and KRAS-G12D and Cell line-B: Bile duct epithelial cells transformed with SV40 LT/ST and KRAS-G12D. Which statement(s) is(are) true about these lines?